Validation strategies for antibodies targeting modified ribonucleotides

Chemical modifications are found on almost all RNAs and affect their coding and noncoding functions. The identification of m6A on mRNA and its important role in gene regulation stimulated the field to investigate whether additional modifications are present on mRNAs. Indeed, modifications including...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Weichmann, Franziska (VerfasserIn) , Dieterich, Christoph (VerfasserIn) , Hett, Robert (VerfasserIn) , Schepers, Aloys (VerfasserIn) , Ito-Kureha, Taku (VerfasserIn) , Flatley, Andrew (VerfasserIn) , Slama, Kaouthar (VerfasserIn) , Hastert, Florian D (VerfasserIn) , Angstman, Nicholas B (VerfasserIn) , Cardoso, M Cristina (VerfasserIn) , König, Julian (VerfasserIn) , Hüttelmaier, Stefan (VerfasserIn) , Canzar, Stefan (VerfasserIn) , Helm, Mark (VerfasserIn) , Heissmeyer, Vigo (VerfasserIn) , Feederle, Regina (VerfasserIn) , Meister, Gunter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: July 7, 202
In: RNA
Year: 2020, Jahrgang: 26, Heft: 10, Pages: 1489-1506
ISSN:1469-9001
DOI:10.1261/rna.076026.120
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1261/rna.076026.120
Verlag, lizenzpflichtig, Volltext: http://rnajournal.cshlp.org/content/26/10/1489
Volltext
Verfasserangaben:Franziska Weichmann, Robert Hett, Aloys Schepers, Taku Ito-Kureha, Andrew Flatley, Kaouthar Slama, Florian D. Hastert, Nicholas B. Angstman, M. Cristina Cardoso, Julian König, Stefan Hüttelmaier, Christoph Dieterich, Stefan Canzar, Mark Helm, Vigo Heissmeyer, Regina Feederle, and Gunter Meister

MARC

LEADER 00000caa a2200000 c 4500
001 1736240145
003 DE-627
005 20260114123442.0
007 cr uuu---uuuuu
008 201022s2020 xx |||||o 00| ||eng c
024 7 |a 10.1261/rna.076026.120  |2 doi 
035 |a (DE-627)1736240145 
035 |a (DE-599)KXP1736240145 
035 |a (OCoLC)1341373125 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Weichmann, Franziska  |e VerfasserIn  |0 (DE-588)1220053449  |0 (DE-627)1736242075  |4 aut 
245 1 0 |a Validation strategies for antibodies targeting modified ribonucleotides  |c Franziska Weichmann, Robert Hett, Aloys Schepers, Taku Ito-Kureha, Andrew Flatley, Kaouthar Slama, Florian D. Hastert, Nicholas B. Angstman, M. Cristina Cardoso, Julian König, Stefan Hüttelmaier, Christoph Dieterich, Stefan Canzar, Mark Helm, Vigo Heissmeyer, Regina Feederle, and Gunter Meister 
264 1 |c July 7, 202 
300 |a 18 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.10.2020 
520 |a Chemical modifications are found on almost all RNAs and affect their coding and noncoding functions. The identification of m6A on mRNA and its important role in gene regulation stimulated the field to investigate whether additional modifications are present on mRNAs. Indeed, modifications including m1A, m5C, m7G, 2′-OMe, and Ψ were detected. However, since their abundances are low and tools used for their corroboration are often not well characterized, their physiological relevance remains largely elusive. Antibodies targeting modified nucleotides are often used but have limitations such as low affinity or specificity. Moreover, they are not always well characterized and due to the low abundance of the modification, particularly on mRNAs, generated data sets might resemble noise rather than specific modification patterns. Therefore, it is critical that the affinity and specificity is rigorously tested using complementary approaches. Here, we provide an experimental toolbox that allows for testing antibody performance prior to their use. 
650 4 |a affinity 
650 4 |a base modifications 
650 4 |a m5C 
650 4 |a m6A 
650 4 |a monoclonal antibodies 
650 4 |a validation 
700 1 |a Dieterich, Christoph  |d 1975-  |e VerfasserIn  |0 (DE-588)130054844  |0 (DE-627)494359269  |0 (DE-576)297972448  |4 aut 
700 1 |a Hett, Robert  |e VerfasserIn  |4 aut 
700 1 |a Schepers, Aloys  |e VerfasserIn  |4 aut 
700 1 |a Ito-Kureha, Taku  |e VerfasserIn  |4 aut 
700 1 |a Flatley, Andrew  |e VerfasserIn  |4 aut 
700 1 |a Slama, Kaouthar  |e VerfasserIn  |4 aut 
700 1 |a Hastert, Florian D  |e VerfasserIn  |4 aut 
700 1 |a Angstman, Nicholas B  |e VerfasserIn  |4 aut 
700 1 |a Cardoso, M Cristina  |e VerfasserIn  |4 aut 
700 1 |a König, Julian  |d 1977-  |e VerfasserIn  |0 (DE-588)136057225  |0 (DE-627)577132555  |0 (DE-576)300805543  |4 aut 
700 1 |a Hüttelmaier, Stefan  |d 1973-  |e VerfasserIn  |0 (DE-588)122419065  |0 (DE-627)705901033  |0 (DE-576)293261296  |4 aut 
700 1 |a Canzar, Stefan  |e VerfasserIn  |4 aut 
700 1 |a Helm, Mark  |e VerfasserIn  |4 aut 
700 1 |a Heissmeyer, Vigo  |e VerfasserIn  |4 aut 
700 1 |a Feederle, Regina  |e VerfasserIn  |4 aut 
700 1 |a Meister, Gunter  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t RNA  |d Cold Spring Harbor, NY : Laboratory Press, 1995  |g 26(2020), 10, Seite 1489-1506  |h Online-Ressource  |w (DE-627)269758844  |w (DE-600)1475737-0  |w (DE-576)25220901X  |x 1469-9001  |7 nnas  |a Validation strategies for antibodies targeting modified ribonucleotides 
773 1 8 |g volume:26  |g year:2020  |g number:10  |g pages:1489-1506  |g extent:18  |a Validation strategies for antibodies targeting modified ribonucleotides 
856 4 0 |u https://doi.org/10.1261/rna.076026.120  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext  |7 1 
856 4 0 |u http://rnajournal.cshlp.org/content/26/10/1489  |x Verlag  |z lizenzpflichtig  |3 Volltext  |7 1 
951 |a AR 
992 |a 20201022 
993 |a Article 
994 |a 2020 
998 |g 130054844  |a Dieterich, Christoph  |m 130054844:Dieterich, Christoph  |d 910000  |d 910100  |e 910000PD130054844  |e 910100PD130054844  |k 0/910000/  |k 1/910000/910100/  |p 12 
999 |a KXP-PPN1736240145  |e 3784523919 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1736240145","id":{"eki":["1736240145"],"doi":["10.1261/rna.076026.120"]},"origin":[{"dateIssuedDisp":"July 7, 202","dateIssuedKey":"2020"}],"relHost":[{"name":{"displayForm":["publ. on behalf of the RNA Society"]},"note":["Gesehen am 12.09.2018"],"title":[{"title_sort":"RNA","title":"RNA"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["1475737-0"],"eki":["269758844"],"issn":["1469-9001"]},"origin":[{"publisher":"Laboratory Press ; HighWire Press","dateIssuedKey":"1995","publisherPlace":"Cold Spring Harbor, NY ; Stanford, Calif.","dateIssuedDisp":"1995-"}],"part":{"text":"26(2020), 10, Seite 1489-1506","issue":"10","extent":"18","year":"2020","volume":"26","pages":"1489-1506"},"disp":"Validation strategies for antibodies targeting modified ribonucleotidesRNA","corporate":[{"display":"RNA Society","role":"isb"}],"pubHistory":["1.1995 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"269758844"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"given":"Franziska","display":"Weichmann, Franziska","family":"Weichmann","role":"aut"},{"family":"Dieterich","display":"Dieterich, Christoph","role":"aut","given":"Christoph"},{"given":"Robert","display":"Hett, Robert","family":"Hett","role":"aut"},{"family":"Schepers","display":"Schepers, Aloys","role":"aut","given":"Aloys"},{"given":"Taku","role":"aut","display":"Ito-Kureha, Taku","family":"Ito-Kureha"},{"family":"Flatley","display":"Flatley, Andrew","role":"aut","given":"Andrew"},{"given":"Kaouthar","role":"aut","family":"Slama","display":"Slama, Kaouthar"},{"given":"Florian D","family":"Hastert","display":"Hastert, Florian D","role":"aut"},{"family":"Angstman","display":"Angstman, Nicholas B","role":"aut","given":"Nicholas B"},{"given":"M Cristina","role":"aut","family":"Cardoso","display":"Cardoso, M Cristina"},{"given":"Julian","role":"aut","family":"König","display":"König, Julian"},{"family":"Hüttelmaier","display":"Hüttelmaier, Stefan","role":"aut","given":"Stefan"},{"given":"Stefan","family":"Canzar","display":"Canzar, Stefan","role":"aut"},{"given":"Mark","display":"Helm, Mark","family":"Helm","role":"aut"},{"display":"Heissmeyer, Vigo","family":"Heissmeyer","role":"aut","given":"Vigo"},{"given":"Regina","role":"aut","family":"Feederle","display":"Feederle, Regina"},{"given":"Gunter","role":"aut","display":"Meister, Gunter","family":"Meister"}],"name":{"displayForm":["Franziska Weichmann, Robert Hett, Aloys Schepers, Taku Ito-Kureha, Andrew Flatley, Kaouthar Slama, Florian D. Hastert, Nicholas B. Angstman, M. Cristina Cardoso, Julian König, Stefan Hüttelmaier, Christoph Dieterich, Stefan Canzar, Mark Helm, Vigo Heissmeyer, Regina Feederle, and Gunter Meister"]},"note":["Gesehen am 22.10.2020"],"language":["eng"],"title":[{"title_sort":"Validation strategies for antibodies targeting modified ribonucleotides","title":"Validation strategies for antibodies targeting modified ribonucleotides"}],"physDesc":[{"extent":"18 S."}]} 
SRT |a WEICHMANNFVALIDATION7202